B.R.A.I.N. Biotechnology Research And Information Network AG (DE000520) | Finanzwire

Basculer en Français

8301	Companies
115073	Keywords
55422	Articles
62513	Press releases

Headlines Articles Press releases B.R.A.I.N. Biotechnology Research And Information Network AG

Home
Companies
B.R.A.I.N. Biotechnology Research And Information Network AG

BRIEF

published on 03/12/2024 at 17:22, 8 months 9 days ago

BRAIN Biotech AG Announces Successful Annual General Meeting Outcomes for FY 2022/23

Annual General Meeting Economic Growth BRAIN Biotech AG Financial Year 2022/23 Research Financing
PRESS RELEASE

published on 03/12/2024 at 17:17, 8 months 9 days ago

Results of the Annual General Meeting 2024 for the financial year 2022/23 of BRAIN Biotech AG
BRAIN Biotech AG announces successful outcomes at the Annual General Meeting 2024, including approval of silent partnership with Hessen. CEO and Chairman express optimism for future growth and targets

Financial Results Annual General Meeting Growth Targets BRAIN Biotech AG Silent Partnership
BRIEF

published on 03/05/2024 at 08:05, 8 months 16 days ago

BRAIN Biotech and AMSilk Announce Breakthrough in Protein Engineering for Sustainable Textiles

BRAIN Biotech AMSilk Protein Engineering Sustainable Textiles Spider Silk
PRESS RELEASE

published on 03/05/2024 at 08:00, 8 months 16 days ago

Collaboration between BRAIN Biotech and AMSilk: Protein engineering successfully improves structural proteins for performance materials
BRAIN Biotech AG and AMSilk collaborate on protein engineering for performance materials, registering their first patent application. The strategic partnership aims for sustainable bio-based solutions in the textile industry

Sustainability BRAIN Biotech AG AMSilk Protein Engineering Performance Materials
BRIEF

published on 02/29/2024 at 20:45, 8 months 20 days ago

BRAIN Biotech AG Announces EUR 5.0 Million Convertible Bond Placement for Growth Initiatives

Non-dilutive Financing Convertible Bond Corporate Strategy BRAIN Biotech AG Financing Growth
PRESS RELEASE

published on 02/29/2024 at 20:40, 8 months 20 days ago

BRAIN Biotech AG successfully placed EUR 5.0 million convertible bond for the financing of further growth initiatives
BRAIN Biotech AG successfully placed EUR 5.0 million convertible bond for financing of growth initiatives. The bonds have an interest rate of 6.52% p.a. and a maturity date of 5 September 2026

Financing Convertible Bond BRAIN Biotech AG Growth Initiatives EUR 5.0 Million
BRIEF

published on 02/29/2024 at 20:11, 8 months 20 days ago

BRAIN Biotech AG Announces Issuance of EUR 5 Million Convertible Bond

Convertible Bonds Shareholder Rights Financial Strategy BRAIN Biotech AG Corporate Financing
PRESS RELEASE

published on 02/29/2024 at 20:06, 8 months 20 days ago

EQS-Adhoc: BRAIN Biotech AG: Issuance of EUR 5 million convertible bond with exclusion of subscription rights
BRAIN Biotech AG issues EUR 5 million convertible bond without subscription rights, to be issued on 5 March 2024. Bonds have 6.52% interest rate and due for repayment in 2026

Convertible Bond BRAIN Biotech AG Subscription Rights Interest Rate Repayment
PRESS RELEASE

published on 02/28/2024 at 07:30, 8 months 22 days ago

3M FY 23/24: BRAIN Biotech looks optimistic to stay on the growth path for fiscal year 2023/24
BRAIN Biotech AG reports optimistic outlook for fiscal year 2023/24 with strong start in BioScience business. Quarterly report includes details on revenue and segment performance

Revenue Growth Financial Performance BRAIN Biotech AG Fiscal Year 2023/24 BioScience Business
BRIEF

published on 02/28/2024 at 07:30, 8 months 22 days ago

BRAIN Biotech AG: Review of the first quarter of the 2023/24 financial year

Financial Report Organic Growth BRAIN Biotech AG BioScience BioProducts

Accesswire

Published on 11/21/2024 at 17:35, 1 hour 25 minutes ago

1upHealth Ranked Number 43 Fastest-Growing Company in North America on the 2024 Deloitte Technology Fast 500(TM)
Published on 11/21/2024 at 17:30, 1 hour 30 minutes ago

SimpliGov and Proof Partner to Offer Online Notarization
Published on 11/21/2024 at 16:30, 2 hours 30 minutes ago

The Rise of DINKs: Dual-Income Couples Without Kids Redefine Financial Priorities in America
Published on 11/21/2024 at 16:01, 2 hours 59 minutes ago

Career Certified Extends Its Investment in the Fast-Growing Architecture, Engineering, and Construction (AEC) Professionals Market with Acquisition of My Contractors License
Published on 11/21/2024 at 16:00, 3 hours ago

Financial Independence Group Announces Exclusive Partnership With Power of Zero and Tax-Free Retirement Expert David McKnight

View all ACCESSWIRE

EQS Group

Published on 11/21/2024 at 18:36, 24 minutes ago

Original-Research: Beaconsmind AG (von First Berlin Equity Research GmbH): BUY
Published on 11/21/2024 at 17:58, 1 hour 1 minute ago

Funding Circle Plc: POS-Transaction in Own Shares
Published on 11/21/2024 at 17:51, 1 hour 8 minutes ago

LIGHTON announces highly successful IPO on Euronext Growth Paris.
Published on 11/21/2024 at 17:51, 1 hour 9 minutes ago

2CRSi SA: 2CRSi supplies Exaion, a subsidiary of the EDF Group, with high-performance immersion servers in North America.
Published on 11/21/2024 at 16:00, 3 hours ago

Director/PDMR Shareholding

Les Echos

Published on 11/21/2024 at 06:58, 12 hours 2 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 23 hours 40 minutes ago

Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 1 day 1 hour ago

MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 1 day 1 hour ago

Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 11 hours ago

Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo

View all LES ECHOS COMFI WIRE